Rapamycin vs. Placebo for the Treatment of Inclusion Body Myositis: improvement of the 6 min walking distance, a functional scale, the FVC and muscle quantitative MRI - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2018

Rapamycin vs. Placebo for the Treatment of Inclusion Body Myositis: improvement of the 6 min walking distance, a functional scale, the FVC and muscle quantitative MRI

Damien Bachasson
Pierre Carlier
  • Fonction : Auteur
Fichier non déposé

Dates et versions

hal-03831822 , version 1 (27-10-2022)

Identifiants

  • HAL Id : hal-03831822 , version 1

Citer

Olivier Benveniste, Jean-Yves Hogrel, Melanie Annoussamy, Damien Bachasson, Aude Rigolet, et al.. Rapamycin vs. Placebo for the Treatment of Inclusion Body Myositis: improvement of the 6 min walking distance, a functional scale, the FVC and muscle quantitative MRI. 2017 ACR/ARHP Annual Meeting, Nov 2017, San Diego, United States. pp.1-3584. ⟨hal-03831822⟩
31 Consultations
0 Téléchargements

Partager

Gmail Mastodon Facebook X LinkedIn More